TRCT
PAVMW

Tower Research Capital (TRC)’s PAVmed Inc. Warrant PAVMW Stock Holding History

Tower Research Capital (TRC)’s Portfolio PAVMW Stock Details PAVMW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1
Closed – – 6516
2021
Q2 		$0 Buy
+1
New +$2 ﹤0.01% 6187

Other funds holding PAVMW

WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Tower Research Capital (TRC)'s PAVMW Position: Q3 2021 in Review

Tower Research Capital (TRC) sold out of PAVmed Inc. Warrant (PAVMW) in Q3 2021, closing a stake of 1 share.

Tower Research Capital (TRC) first reported a position in PAVMW in Q2 2021 and held it in 1 quarter. The position peaked at $0 in Q2 2021. 3 funds tracked by Wall St. Rank hold PAVMW as of Q3 2021.

  • Tower Research Capital (TRC) reported no remaining PAVmed Inc. Warrant position as of Q3 2021 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1 PAVmed Inc. Warrant share in Q3 2021.
  • Tower Research Capital (TRC) first reported a position in PAVmed Inc. Warrant in Q2 2021 and held it in 1 quarter.
  • Tower Research Capital (TRC)'s PAVmed Inc. Warrant position peaked at $0 in Q2 2021.
  • 3 funds tracked by Wall St. Rank held PAVmed Inc. Warrant as of Q3 2021.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.